How can I take care of you? The dermatologist meets patients' needs during the COVID-19 pandemic.
作者信息
Radi Giulia, Simonetti Oriana, Diotallevi Federico, Campanati Anna, Brisigotti Valerio, Molinelli Elisa, Offidani Annamaria
机构信息
Dermatological Clinic, Department of Clinical and Molecular Sciences, Polytechnic University of the Marche Region, Ancona, Italy.
出版信息
Dermatol Ther. 2020 Jul;33(4):e13740. doi: 10.1111/dth.13740. Epub 2020 Jun 30.
Abstract
摘要
相似文献
1
How can I take care of you? The dermatologist meets patients' needs during the COVID-19 pandemic.
Dermatol Ther. 2020 Jul;33(4):e13740. doi: 10.1111/dth.13740. Epub 2020 Jun 30.
2
Where do we stand as dermatologists in combat with COVID-19.
Dermatol Ther. 2020 Jul;33(4):e13638. doi: 10.1111/dth.13638. Epub 2020 Jun 23.
3
A dermatologist's perspective of the COVID-19 outbreak.
Dermatol Ther. 2020 Jul;33(4):e13538. doi: 10.1111/dth.13538. Epub 2020 Jun 23.
4
Dermatologic treatments in the era of COVID-19 pandemic-Data and Hypothesis.
Dermatol Ther. 2020 Jul;33(4):e13562. doi: 10.1111/dth.13562. Epub 2020 May 26.
5
Impact of COVID-19 outbreak on dermatology services: Dermatology in isolation.
Dermatol Ther. 2020 Jul;33(4):e13552. doi: 10.1111/dth.13552. Epub 2020 May 22.
6
Resuming work gradually in the context of COVID-19: Experience from a tertiary dermatology department in China.
Dermatol Ther. 2020 Jul;33(4):e13554. doi: 10.1111/dth.13554. Epub 2020 Jun 15.
7
The skin in the era of coronavirus pandemic.
J Eur Acad Dermatol Venereol. 2020 Jul;34(7):1384-1385. doi: 10.1111/jdv.16718.
8
Will teledermatology be the silver lining during and after COVID-19?
Dermatol Ther. 2020 Jul;33(4):e13643. doi: 10.1111/dth.13643. Epub 2020 Jun 4.
9
Teledermatology during COVID-19 pandemic: Ethical and legal considerations about the principles of treatment prescription and privacy.
Dermatol Ther. 2020 Jul;33(4):e13781. doi: 10.1111/dth.13781. Epub 2020 Jul 2.
10
Is the Coronavirus (COVID-19) Pandemic an Indication to Temporarily Modify Dermatological Management Plans?
J Drugs Dermatol. 2020 Apr 1;19(4):436.
引用本文的文献
1
Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions.
Molecules. 2023 Dec 13;28(24):8064. doi: 10.3390/molecules28248064.
2
Vitiligo, from Pathogenesis to Therapeutic Advances: State of the Art.
Int J Mol Sci. 2023 Mar 3;24(5):4910. doi: 10.3390/ijms24054910.
3
Biological Treatments for Pediatric Psoriasis: State of the Art and Future Perspectives.
Int J Mol Sci. 2022 Sep 22;23(19):11128. doi: 10.3390/ijms231911128.
4
Latest combination therapies in psoriasis: Narrative review of the literature.
Dermatol Ther. 2022 Oct;35(10):e15759. doi: 10.1111/dth.15759. Epub 2022 Aug 26.
5
Vaccines Against SARS-CoV-2 in Psoriasis Patients on Immunosuppressive Therapy: Implications of Vaccination Nationwide Campaign on Clinical Practice in Italy.
Dermatol Ther (Heidelb). 2021 Dec;11(6):1889-1903. doi: 10.1007/s13555-021-00610-z. Epub 2021 Sep 29.
6
Safety and Efficacy of Vaccines during COVID-19 Pandemic in Patients Treated with Biological Drugs in a Dermatological Setting.
Healthcare (Basel). 2021 Apr 1;9(4):401. doi: 10.3390/healthcare9040401.
7
Skin manifestations of COVID-19 in children: Part 3.
Clin Exp Dermatol. 2021 Apr;46(3):462-472. doi: 10.1111/ced.14483. Epub 2020 Nov 18.
8
Telogen effluvium related to post severe Sars-Cov-2 infection: Clinical aspects and our management experience.
Dermatol Ther. 2021 Jan;34(1):e14547. doi: 10.1111/dth.14547. Epub 2020 Nov 23.
9
Time to restart: protocol of resumption of activities of a dermatological clinic of a level II hospital in the COVID-19 era.
Int J Dermatol. 2020 Nov;59(11):1411-1413. doi: 10.1111/ijd.15187. Epub 2020 Sep 23.
10
Hydroxychloroquine, dermatology, and SARS-CoV-2: Updating an old association.
J Med Virol. 2021 Jan;93(1):5-7. doi: 10.1002/jmv.26322. Epub 2020 Jul 28.
本文引用的文献
1
Active implications for dermatologists in 'SARS-CoV-2 ERA': Personal experience and review of literature.
J Eur Acad Dermatol Venereol. 2020 Aug;34(8):1626-1632. doi: 10.1111/jdv.16646.
2
Skin involvement in SARS-CoV-2 infection: Case series.
J Med Virol. 2020 Nov;92(11):2332-2334. doi: 10.1002/jmv.26012. Epub 2020 Jun 2.
3
How Dermatologists Can Learn and Contribute at the Leading Edge of the COVID-19 Global Pandemic.
JAMA Dermatol. 2020 Jul 1;156(7):733-734. doi: 10.1001/jamadermatol.2020.1438.
4
Teledermatology in the wake of COVID-19: Advantages and challenges to continued care in a time of disarray.
J Am Acad Dermatol. 2020 Jul;83(1):168-169. doi: 10.1016/j.jaad.2020.04.080. Epub 2020 Apr 22.
5
Global coronavirus pandemic (2019-nCOV): implication for an Italian medium size dermatological clinic of a II level hospital.
J Eur Acad Dermatol Venereol. 2020 May;34(5):e213-e214. doi: 10.1111/jdv.16386.
6
Teledermatology: A Review and Update.
Am J Clin Dermatol. 2018 Apr;19(2):253-260. doi: 10.1007/s40257-017-0317-6.
7
Telemedicine in dermatology: findings and experiences worldwide - a systematic literature review.
J Eur Acad Dermatol Venereol. 2018 Feb;32(2):215-224. doi: 10.1111/jdv.14341. Epub 2017 Jul 4.
8
Global Skin Disease Morbidity and Mortality: An Update From the Global Burden of Disease Study 2013.
JAMA Dermatol. 2017 May 1;153(5):406-412. doi: 10.1001/jamadermatol.2016.5538.
Zotero 插件